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Abstract
Background: The annual number of hip arthroplasties is increasing combined with the aging population
worldwide. In accordance with the increasing number of primary hip arthroplasties, the number of revision total hip
arthroplasties (THAs) is expected to increase. The incidence and burden of revision THAs in the United States and
have been reported by registry studies. To identify potential differences according to ethnics and regional practice,
it is important to obtain data from East Asia. Nevertheless, there has been a lack of studies on the burden and
future projection of revision THA based on a large-scale database in East Asia. The purpose of this study was to
evaluate annual incidence and burden of revision THAs and to project the future burden in South Korea.
Methods: We identified primary THAs, primary hemiarthroplasties (HAs) and revision THAs, which were performed
from 2010 to 2018, using database of Health Insurance and Review and Assessment (HIRA); nation-wide medical
claim system of South Korea. The annual incidence rates (per 100,000) of primary THA, primary HA and revision
THA, and the annual burden of revision THA; the number of revision THAs divided by the sum of primary hip
arthroplasties and revision THAs, were calculated. The future burden of revision THAs were projected through 2030
using generalized linear model with Quasi-poisson regression.
Results: During the 9-year period, the annual incidences of primary THA, primary HA and revision THA increased by
47, 29 and 3%, respectively, while the revision burden decreased from 0.13 to 0.10. Compared to 2018, the annual
incidences of primary THA, HA, and revision THA were projected to increase by 7.2, 2.3 and 1.1% per year,
respectively, whereas the burden of revision THA was projected to decrease to 0.07 in 2030.
Conclusion: Trends of revision THA in South Korea were similar with those of national registry studies from the
United States. The annual incidence of revision THA has steadily increased, whereas its burden has decreased.
Findings of our study could be used for epidemiological comparison between Western countries and East Asia as
well as for the establishment of medical policies of revision THA in East Asian countries.
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Background
Total hip arthroplasty (THA) is one of the most effective
orthopedic procedures and has been utilized as the treat-
ment of choice for the patients with advanced osteoarthritis
of the hip [1–4]. However, THA is associated with early
and late failures and inevitably necessitates revision surger-
ies, which is a socioeconomic burden worldwide [5–8].
In the United States, the annual number of revision
THA has steadily increased, [6, 9] but the burden of re-
vision THA; the proportion of revision THAs to overall
sum of hip arthroplasties; primary THAs, primary HAs
and revision THAs, was disconcerting since 1990s [10].
There might be regional differences in the burden of
revision THA according to ethnicity, implant design, fix-
ation method; cemented versus cementless, and bearing
surface [11].
Number of studies outside the United States reported
the annual incidence of revision THA [12–16]. Epi-
demiological trend similar to the United States; increase
in the number of revision THA and decrease in the bur-
den of revision THA, was observed in other countries
including Australia, New Zealand, England, Wales and
Sweden except for Norway [17].
Nevertheless, there is lack of epidemiological study of
revision THA in East Asia, which is necessary for re-
gional comparison of the revision THA burden between
Western countries and East Asia and for awareness of
worldwide tendency.
The purpose of this study was 1) to analyze the burden
of hip arthroplasty including primary THA, HA and re-
vision THA from 2010 to 2018 and 2) to provide a fu-




This is a retrospective study using secondary register-
based data analysis. The Korean Health Insurance and
Review and Assessment (HIRA) database includes med-
ical claims from entire South Korean institutions.
Ninety-seven percent of South Korean population is
obliged to register into the Korea National Health Insur-
ance Program (KNHIP).
The remaining 3% of the population is covered by the
Medical Aid program, which is paid by the government.
Data of patients under the.
Medical Aid program are submitted to HIRA in the
same manner as KNHIP. Therefore, the HIRA database
included the entire South Korean population.
The HIRA database contains demographics, diagnoses,
procedures and prescriptions of all THA patients in
South Korea.
We identified primary THAs, primary HAs and revi-
sion THAs, which had been done from January 2010 to
May 2014 in South Korea, using Electronic Data Inter-
change (EDI) codes of THA (N0711) and hemiarthro-
plasty (HA) (N0715).
Since June 2014, the Korean National Health Insur-
ance Service (NHIS) added complex surgical procedure
codes (total joint arthroplasty-hip (complex) (N2070)
and hemiarthroplasty-hip (complex) (N2710)) for the
specific 21 complex conditions for reimbursement of an
additional cost to the medical institute (Supplement. 1).
THAs and HAs, which had been done from June 2014
to December 2018, were identified using 4 procedure
codes (N0711, N2070, N0715, and N2710).
Revision THAs were identified using procedural codes
of simple revision THA (N1711, N1721, N1715, N1725)
and complex revision THA (N3710, N3720, N4710,
N4720).
Data and statistical analyses
The numbers and crude incidence rates (per 100,000) of
THA, HA, and revision THA procedures were calculated
according to age and gender. Annual incidence rate of
each arthroplasty was calculated by dividing the number
of each procedure at each year with corresponding year-
specific South Korean population. The annual popula-
tion data were acquired from database of the Korean
Statistical Information Service. Then, the incidence rate
Table 1 Change of hip arthroplasties in South Korea from 2010 to 2018
Type of Surgery No. of procedures
2010 2011 2012 2013 2014 2015 2016 2017 2018
Primary THA 7657 7917 8673 9278 9520 10,357 11,036 11,227 11,548
HA 10,918 11,532 12,561 12,949 12,941 13,737 13,420 13,613 14,408
Revision THA 2728 2671 2777 2701 2752 2826 2875 3032 2870
Population 50,515,666 50,734,284 50,948,272 51,141,463 51,327,916 51,529,338 51,696,216 51,778,544 51,826,059
Primary THA incidence 15.16 15.60 17.02 18.14 18.55 20.10 21.35 21.68 22.28
HA incidence 21.61 22.73 24.65 25.32 25.21 26.66 25.96 26.29 27.80
Revision THA incidence 5.40 5.26 5.45 5.28 5.36 5.48 5.56 5.86 5.54
Burden of revision THA 0.13 0.12 0.12 0.11 0.11 0.10 0.10 0.10 0.10
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Fig. 1 Number of primary total hip arthroplasty a, hemiarthroplasty b, and revision total hip arthroplasty c in each gender (THA, total hip
arthroplasty; HA, hemiarthroplasty; RevTHA, revision total hip arthroplasty)
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per 100,000 person-year was calculated. The annual
rates were stratified according to age and gender.
The burden of revision THA was defined as the pro-
portion of revision THAs to overall sum of hip arthro-
plasties; primary THAs, primary HAs and revision
THAs [18]. The future projection of THA, HA and revi-
sion THAs through 2030 were calculated by using gen-
eralized linear model with Quasi-poisson regression.
Demographics-based projections through 2030 were ob-
tained from the Korean Statistical Information Service.
Results
Annual incidences of primary THA, primary HA and
revision THA from 2010 to 2018
From 2010 to 2018, 87,213 primary THAs, 116,079 pri-
mary HAs, and 25,232 revision THAs were done in
South Korea. The number of each surgery at each year is
summarized in Table 1.
During the 9-year period, the annual crude incidence
of primary THA and that of primary HA increased by
47% (15.2/100,000 in 2010 to 22.3/100,000 in 2018) and
29% (21.6/100,000 in 2010 to 27.8/100,000 in 2018), re-
spectively. Nevertheless, the annual incidence rate of re-
vision THA remained stable at an average of 5.5/100,000
(range, 5.4–5.9/100,000) (Fig. 1), and the burden of revi-
sion THA decreased from 0.13 to 0.10 (Table 1).
Overall, 86% of primary HA patients were ≥ 70 years
of age, whereas 50% of primary THA patients and 29%
of revision THA patients were < 60 years of age
(Table 2).
The annual number of primary THA increased in age
groups of 50–59 years, 60–69 years, 70–79 years and ≧
80 years, whereas the annual number of HA increased
only in the age group of ≧80 years. The annual number
of revision THA slightly increased in age groups of 70–
79 years and ≧ 80 years (Fig. 2).
In 2018, the peak age of primary THA was 50–59 years
in men and 70–79 years in women. The number of HA
abruptly increased after 50 years, especially in women.
The peak age of revision THA was 60–69 years in men
and 70–79 years in women (Fig. 3).
The burden of revision THA slightly decreased from
0.13 in 2010 to 0.10 in 2018.
Projection of annual numbers of primary THA, primary
HA and revision THA to 2030
In our prediction model, the numbers of primary THA
and HA were predicted to increase to 21,465 (95% confi-
dence interval (CI) 16,792 – 27,451) and 18,384 (95% CI
16,162 – 20,918), respectively, while the number of revi-
sion THA was predicted to be 3241 (95% CI 3042 –
3454) in 2030 (Fig. 4). Compared to 2018, the annual in-
cidences of primary THA, HA, and revision THA were
projected to increase by 7.2, 2.3 and 1.1% per year, re-
spectively, whereas the burden of revision THA was pro-
jected to decrease to 0.07 in 2030.
Discussion
Our study showed that the annual crude incidences of
primary THA and primary HA increased by 47 and 29%,
respectively, whereas and revision THA increased by
only 3% and the burden of revision THA decreased from
0.13 to 0.10 during the period from 2010 to 2018 in
South Korea. The burden of revision THA was projected
to decrease to 0.07 in 2030.
These trends were similar with those of previous na-
tional registry studies from the United States, United
Kingdom and Taiwan (Table 3) [9, 13, 14, 19, 20].
In the study of Wolf et al. the revision burden reduced
from 0.20 in 1991–1993 to 0.17 in 2006–2008 [19]. An-
other study by Schwartz et al. showed similar decrease
Table 2 Demographic characteristic of patients who had hip replacements from 2010 to 2018 in Korea
Primary THA (n = 87,213) HA (n = 116,079) Revision THA (n = 25,232)
Gender (%)
Male 46,276 (53%) 30,664 (26%) 14,224 (56%)
Female 40,937 (47%) 85,415 (74%) 11,008 (44%)
Age category
10–19 years 156 24 21
20–29 years 1952 71 102
30–39 years 6628 330 540
40–49 years 12,639 1069 1995
50–59 years 21,968 3512 4600
60–69 years 20,807 11,270 6975
70–79 years 18,000 42,723 7757
≥ 80 years 5063 57,080 3109
THA total hip arthroplasty, HA hemiarthroplasty
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Fig. 2 Number of total hip arthroplasty a, hemiarthroplasty b, and revision total hip arthroplasty c stratified by age group from 2010 to 2018
(THA, total hip arthroplasty; HA, hemiarthroplasty; RevTHA, revision total hip arthroplasty)
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Fig. 3 Number of total hip arthroplasty a, hemiarthroplasty b, and revision total hip arthroplasty c in each age group in 2018 (THA, total hip
arthroplasty; HA, hemiarthroplasty; RevTHA, revision total hip arthroplasty)
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Fig. 4 Projection of future cases of total hip arthroplasty a, hemiarthroplasty b, and revision total hip arthroplasty c in South Korea (THA, total hip
arthroplasty; HA, hemiarthroplasty; RevTHA, revision total hip arthroplasty)
Park et al. BMC Musculoskeletal Disorders          (2021) 22:375 Page 7 of 9
of the revision burden from 0.19 in 2001 to 0.13 in
2010 [21].
In 2014, Kurtz et al. estimated hip arthroplasty data of
from the Nationwide Inpatient Sample in United States
and projected the number of hip arthroplasties and the
burden of revision THA. In their study, the number of
primary THA and that of revision THA increased by
6.0% and by 10.8%, respectively, and the revision burden
increased from 0.135 to 0.141 from 2009 to 2010. The
numbers were expected to increase by 74% for primary
THA and 36% for revision THA, but the revision burden
was projected to decrease from 0.14 to 0.11 between
2010 and 2020 [9].
In 2019, Heckmann et al. compared the hip arthroplasty
data from American Joint Replacement Registry (AJRR) to
national registry data of Australia, New Zealand, England,
Wales, Sweden and Norway [17]. In the AJRR, the burden
of revision THA decreased from 0.14 in 2014 to 0.09 in
2016. The burden of revision THA decreased in most
counties except for Norway. The burden decreased from
0.12 to 0.11 in Australia, from 0.15 to 0.12 in New Zea-
land, from 0.10 to 0.08 in England/Wales, and from 0.11
to 0.10 in Sweden [17]. However, in Norway, the burden
slightly increased from 0.135 to 0.138 [17].
As opposed to the study of Heckmann et al., Patel et al.
reported an increase of revision THA burden in England
and Wales from 0.09 in 2008 to 0.11 in 2012 [14].
The annual incidence rate (per 100,000 person-year)
of primary THA and revision THA increased from
101 to 134 and from 19.2 to 21.1 per 100,000 Danish
inhabitants from 1996 to 2002, respectively. The inci-
dence rates of primary THA and revision THA in-
creased by 30 and 10% during the same period [15].
In line with this finding, the incidence of THA has
also increased in South Korea during last decade.
Aging of Korean population could be one of the main
reasons of our findings.
In a previous study of THA epidemiology from South
Korea, both the number and incidence rate of primary
hip arthroplasty increased steadily from 2007 to 2011,
but there was no significant change in the number of re-
vision THA during the period [16].
The worldwide trend of decrease in the burden of revi-
sion THA (Table 3) means relatively small increase in
the number of revision THAs compared to a substantial
growth in the number of primary hip arthroplasties.
There might be some explanations for this decrease of
the revision burden. First, surgical technique for primary
THA has been improved with time [22]. Second, modern
technologies of hip prostheses, especially, bearing sur-
faces might have prolonged the longevity of primary
THA [23].
The strength of our study was that the study is based
on national registry data. The results cover nearly 100%
of all hip arthroplasties in South Korea. Such data are
only available in few countries. Our study was based on
national registry data and has inherent limitation. We
could not identify the reason of arthroplasty, type of ori-
ginal prosthesis, type of fixation; cementless versus
cemented, bearings surfaces and the reason of revision
surgery in patients undergoing revision THA, because of
de- identification of the HIRA database.
Conclusions
In this study, we confirmed an increase in number and
incidence of revision THA as well as primary THA and
HA from 2010 to 2018 in South Korea. The burden of
revision THA in that period gradually decreased from
0.13 to 0.10, which was similar to reports from Western
countries.
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